HA-VHL wt-pBabe-puro Citations (11)
Originally described in: Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations.Li L, Zhang L, Zhang X, Yan Q, Minamishima YA, Olumi AF, Mao M, Bartz S, Kaelin WG Mol Cell Biol. 2007 Aug . 27(15):5381-92. PubMed Journal
Articles Citing HA-VHL wt-pBabe-puro
| Articles |
|---|
| Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Vanharanta S, Shu W, Brenet F, Hakimi AA, Heguy A, Viale A, Reuter VE, Hsieh JJ, Scandura JM, Massague J. Nat Med. 2013 Jan;19(1):50-6. doi: 10.1038/nm.3029. Epub 2012 Dec 9. PubMed |
| Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth. Vindrieux D, Devailly G, Augert A, Le Calve B, Ferrand M, Pigny P, Payen L, Lambeau G, Perrais M, Aubert S, Simonnet H, Dante R, Bernard D. Oncotarget. 2014 Feb 28;5(4):1004-13. PubMed |
| Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function. German P, Bai S, Liu XD, Sun M, Zhou L, Kalra S, Zhang X, Minelli R, Scott KL, Mills GB, Jonasch E, Ding Z. Oncogene. 2016 Mar 14. doi: 10.1038/onc.2016.40. PubMed |
| VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma. Yao X, Tan J, Lim KJ, Koh J, Ooi WF, Li Z, Huang D, Xing M, Chan YS, Qu JZ, Tay ST, Wijaya G, Lam YN, Hong JH, Lee-Lim AP, Guan P, Ng MSW, He CZ, Lin JS, Nandi T, Qamra A, Xu C, Myint SS, Davies JOJ, Goh JY, Loh G, Tan BC, Rozen SG, Yu Q, Tan IBH, Cheng CWS, Li S, Chang KTE, Tan PH, Silver DL, Lezhava A, Steger G, Hughes JR, Teh BT, Tan P. Cancer Discov. 2017 Nov;7(11):1284-1305. doi: 10.1158/2159-8290.CD-17-0375. Epub 2017 Sep 11. PubMed |
| NF-kappaB-Dependent Lymphoid Enhancer Co-option Promotes Renal Carcinoma Metastasis. Rodrigues P, Patel SA, Harewood L, Olan I, Vojtasova E, Syafruddin SE, Zaini MN, Richardson EK, Burge J, Warren AY, Stewart GD, Saeb-Parsy K, Samarajiwa SA, Vanharanta S. Cancer Discov. 2018 Jul;8(7):850-865. doi: 10.1158/2159-8290.CD-17-1211. Epub 2018 Jun 6. PubMed |
| Endogenous HIF2A reporter systems for high-throughput functional screening. Zaini MN, Patel SA, Syafruddin SE, Rodrigues P, Vanharanta S. Sci Rep. 2018 Aug 13;8(1):12063. doi: 10.1038/s41598-018-30499-2. PubMed |
| Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer. Felipe-Abrio B, Verdugo-Sivianes EM, Saez C, Carnero A. Cancers (Basel). 2019 Feb 18;11(2). pii: cancers11020235. doi: 10.3390/cancers11020235. PubMed |
| Structural basis of Cullin 2 RING E3 ligase regulation by the COP9 signalosome. Faull SV, Lau AMC, Martens C, Ahdash Z, Hansen K, Yebenes H, Schmidt C, Beuron F, Cronin NB, Morris EP, Politis A. Nat Commun. 2019 Aug 23;10(1):3814. doi: 10.1038/s41467-019-11772-y. PubMed |
| An improved platform for functional assessment of large protein libraries in mammalian cells. Matreyek KA, Stephany JJ, Chiasson MA, Hasle N, Fowler DM. Nucleic Acids Res. 2020 Jan 10;48(1):e1. doi: 10.1093/nar/gkz910. PubMed |
| Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines. Wang X, Hu J, Fang Y, Fu Y, Liu B, Zhang C, Feng S, Lu X. Cells. 2022 Jan 29;11(3). pii: cells11030472. doi: 10.3390/cells11030472. PubMed |
| Deregulated expression of the 14q32 miRNA cluster in clear cell renal cancer cells. Chhabra R, Guergues J, Wohlfahrt J, Rockfield S, Espinoza Gonzalez P, Rego S, Park MA, Berglund AE, Stevens SM Jr, Nanjundan M. Front Oncol. 2023 Apr 17;13:1048419. doi: 10.3389/fonc.2023.1048419. eCollection 2023. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.